Measles-containing-vaccine second-dose (MCV2) immunization coverage in Europe (WHO region)

Europe (WHO region): Measles-containing-vaccine second-dose (MCV2) immunization coverage was 89.0% in 2025. ▲ Rising

Latest (2025)
89.0%
Change on year
unchanged
Rank
3rd
of 11 groups
All-time high
91.0%
in 2018
All-time low
48.0%
in 2000
Years of data
26
2000–2025

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Europe (WHO region), 2000–2025

0204060801002000201220252000: 482001: 622002: 702003: 732004: 772005: 772006: 752007: 762008: 752009: 732010: 802011: 832012: 832013: 892014: 892015: 892016: 882017: 902018: 912019: 912020: 902021: 902022: 902023: 892024: 892025: 89

Source: World Health Organization, Global Health Observatory.

Analysis

In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Europe (WHO region) stood at 89.0%.

The figure is unchanged over ten years.

Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Europe (WHO region) peaked at 91.0% in 2018 and was at its lowest, 48.0%, in 2000.

The long-run direction has been consistently rising across the 26 years of available data.

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Europe (WHO region), year by year

Annual values for Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC) in Europe (WHO region), 2000 to 2025.
Year Value Change
2000 48.0%
2001 62.0% +29.2%
2002 70.0% +12.9%
2003 73.0% +4.3%
2004 77.0% +5.5%
2005 77.0% +0.0%
2006 75.0% -2.6%
2007 76.0% +1.3%
2008 75.0% -1.3%
2009 73.0% -2.7%
2010 80.0% +9.6%
2011 83.0% +3.8%
2012 83.0% +0.0%
2013 89.0% +7.2%
2014 89.0% +0.0%
2015 89.0% +0.0%
2016 88.0% -1.1%
2017 90.0% +2.3%
2018 91.0% +1.1%
2019 91.0% +0.0%
2020 90.0% -1.1%
2021 90.0% +0.0%
2022 90.0% +0.0%
2023 89.0% -1.1%
2024 89.0% +0.0%
2025 89.0% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 70.6% 48.0% 77.0% 10
2010s 87.3% 80.0% 91.0% 10
2020s 89.5% 89.0% 90.0% 6

Countries ranked near Europe (WHO region)

  1. 1 Uzbekistan 99.0% compare
  2. 1 Saudi Arabia 99.0% compare
  3. 1 Bhutan 99.0% compare
  4. 1 Maldives 99.0% compare
  5. 1 Korea, Democratic People's Republic of 99.0% compare
  6. 1 Palestine, State of 99.0% compare
  7. 1 Bahrain 99.0% compare
  8. 1 Hungary 99.0% compare
  9. 1 Niue 99.0% compare
  10. 1 Brunei Darussalam 99.0% compare
  11. 1 Oman 99.0% compare
  12. 1 Cuba 99.0% compare
  13. 1 Saint Vincent and the Grenadines 99.0% compare
  14. 1 Qatar 99.0% compare
  15. 1 Turkmenistan 99.0% compare

See the full ranking of 207 places →

More health data for Europe (WHO region)

All data for Europe (WHO region) →

Frequently asked questions

What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Europe (WHO region)?
Measles-containing-vaccine second-dose (mcv2) immunization coverage in Europe (WHO region) was 89.0% in 2025, according to World Health Organization, Global Health Observatory.
What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Europe (WHO region)?
The highest recorded value was 91.0% in 2018.
What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Europe (WHO region)?
The lowest recorded value was 48.0% in 2000.
How does Europe (WHO region) rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
Europe (WHO region) ranks 3rd out of 11 groups with data for 2025.
Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Europe (WHO region)?
Over the last ten years it is unchanged. The long-run trend across the full record is rising.
Where does this Europe (WHO region) data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Europe (WHO region). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 03 September 2026, from https://health.statizoid.com/stat/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/europe-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/europe-who-region/">Measles-containing-vaccine second-dose (MCV2) immunization coverage in Europe (WHO region)</a> — Statizoid

About this data

Indicator
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 5,363 data points, 2000–2025
Last refreshed